PATENT CLAIM ANALYSIS

Application Number: 16221274
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["514", "300000"]

Abstract:
The invention relates to compounds of formula (I): wherein Q, A 1 , A 2 , A 3 , A 5 , A 6 , A 7 , A 8 , R 4a , R 4b  and R 5  are as described herein. Compounds of formula (I) and pharmaceutical compositions thereof are useful in the treatment of diseases and disorders in which undesired or over-activation of NF-kB signaling is observed.

Claim (Index 35):
A method of making a compound of formula (C): wherein A 1 , A 2 , A 3 , R 6  and n are as defined in  claim 26 , comprising: (i) reacting a compound of formula (C-1): wherein X is \u2014Cl, \u2014Br, \u2014I, \u2014OS(O) 2 CF 3 , \u2014OC(O)CH 3 , \u2014OS(O) 2 CH 3 , \u2014OS(O) 2 (4-CH 3 C 6 H 4 ), or \u2014N 2 + ; and LG is a leaving group; with a compound of formula (C-2): to form a compound of formula (C-3): and\n (ii) converting the compound of formula (C-3) to the compound of formula (C).

Metadata:
- Claim Count in Document: 5.0
- Percentile: 98.0
- Lexical Diversity: 1.59184
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['16220963', '15314938', '15026250', '14378975', '15904143']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7275630070514111
- 35 USC 102 Novelty (BERT): 0.5859386217122419
- Combined Prediction Score: 0.7134005685174942
- Mean Citation Score: 329.27391
- Max Citation Score: 485.14618
- Similarity Product: 420.1528415953863

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test